Literature DB >> 8469373

Neuropeptide Y stimulates DNA synthesis in vascular smooth muscle cells.

Y Shigeri1, M Fujimoto.   

Abstract

Neuropeptide Y (NPY) stimulated DNA synthesis in porcine aortic smooth muscle cells in a concentration-dependent manner. [Leu31, Pro34]NPY, a Y1-specific agonist, was several hundred times more potent than NPY(13-36), which preferentially bound to Y2 receptors, for stimulating DNA synthesis. On the other hand, human pancreatic polypeptide had no effect. The potency of NPY and related peptides for stimulating DNA synthesis paralleled their potency for increasing the cytosolic free Ca2+ concentration in the cells. Pertussis toxin treatment completely blocked both effects of the peptides. Thus, NPY may induce Ca2+ mobilization and stimulation of DNA synthesis in vascular smooth muscle cells via Y1 receptors whose signal transduction system involves pertussis toxin-sensitive GTP-binding protein(s).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8469373     DOI: 10.1016/0304-3940(93)90337-k

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

1.  Deletion of the neuropeptide Y (NPY) Y1 receptor gene reveals a regulatory role of NPY on catecholamine synthesis and secretion.

Authors:  Cláudia Cavadas; Daniel Céfai; Joana Rosmaninho-Salgado; Maria Augusta Vieira-Coelho; Eduardo Moura; Nathalie Busso; Thierry Pedrazzini; Daniela Grand; Samuel Rotman; Bernard Waeber; Jean-François Aubert; Eric Grouzmann
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-23       Impact factor: 11.205

Review 2.  Novel roles of perivascular nerves on neovascularization.

Authors:  Lei Hao; Zhongmin Zou; Hong Tian; Yubo Zhang; Chuan Song; Huchuan Zhou; Lei Liu
Journal:  Neurol Sci       Date:  2014-11-29       Impact factor: 3.307

3.  Chronic type II diabetes mellitus leads to changes in neuropeptide Y receptor expression and distribution in human myocardial tissue.

Authors:  Robina Matyal; Feroze Mahmood; Michael Robich; Hiliary Glazer; Kamal Khabbaz; Philip Hess; Cesario Bianchi; Robert Hagberg; Shu-Xu Hu; Frank W Sellke
Journal:  Eur J Pharmacol       Date:  2011-04-28       Impact factor: 4.432

4.  NPY/Y₁ receptor-mediated vasoconstrictory and proliferative effects in pulmonary hypertension.

Authors:  S Crnkovic; B Egemnazarov; P Jain; U Seay; N Gattinger; L M Marsh; Z Bálint; G Kovacs; B Ghanim; W Klepetko; R T Schermuly; N Weissmann; A Olschewski; G Kwapiszewska
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

Review 5.  Neuropeptide Y and neurovascular control in skeletal muscle and skin.

Authors:  Gary J Hodges; Dwayne N Jackson; Louis Mattar; John M Johnson; J Kevin Shoemaker
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-07-01       Impact factor: 3.619

6.  Sympathetic nervous system-targeted neuropeptide Y overexpression in mice enhances neointimal formation in response to vascular injury.

Authors:  Suvi T Ruohonen; Ken Abe; Mia Kero; Laura Toukola; Saku Ruohonen; Matias Röyttä; Markku Koulu; Ullamari Pesonen; Zofia Zukowska; Eriika Savontaus
Journal:  Peptides       Date:  2008-12-24       Impact factor: 3.750

7.  Interactions of multiple signaling pathways in neuropeptide Y-mediated bimodal vascular smooth muscle cell growth.

Authors:  Jennifer Pons; Joanna Kitlinska; Danielle Jacques; Claudine Perreault; Moni Nader; Lindsay Everhart; Ying Zhang; Zofia Zukowska
Journal:  Can J Physiol Pharmacol       Date:  2008-07       Impact factor: 2.273

Review 8.  Current Insights Into the Role of Neuropeptide Y in Skin Physiology and Pathology.

Authors:  Zoya T Anderson; Alex D Dawson; Andrzej T Slominski; Melissa L Harris
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-28       Impact factor: 5.555

9.  Neuropeptide Y in the noradrenergic neurons induces the development of cardiometabolic diseases in a transgenic mouse model.

Authors:  Suvi T Ruohonen; Ullamari Pesonen; Eriika Savontaus
Journal:  Indian J Endocrinol Metab       Date:  2012-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.